wiki pageCreated: 2026-04-02T07:19:15By: crosslink-migrationQuality:
50%✓ SciDEXID: wiki-proteins-htr2b-protein
📖 Wiki Page
protein699 wordssynced 2026-04-02
Serotonin Receptor 2B Protein
Introduction
Serotonin Receptor 2B Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Serotonin Receptor 2B Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The HTR2B protein belongs to the GPCR, Class A, Serotonin family. The protein structure consists of seven transmembrane domains connected by three extracellular and three intracellular loops. The ligand-binding pocket is located within the transmembrane domains. Key structural features include a conserved DRY motif at the cytoplasmic end of TM3, which is critical for G protein coupling. The third intracellular loop contains major determinants for Gq protein specificity. The C-terminal tail contains serine/threonine residues that serve as phosphorylation sites for receptor desensitization and internalization.
Normal Function
The serotonin 2B receptor (5-HT2B) is a Gq-coupled GPCR that activates phospholipase C (PLC) upon serotonin binding. This leads to generation of inositol trisphosphate (IP3) and diacylglycerol (DAG), causing intracellular calcium release and protein kinase C (PKC) activation. 5-HT2B is unique among 5-HT2 receptors for its ability to activate multiple signaling pathways including ERK, PI3K/Akt, and RhoA. In the brain, 5-HT2B is expressed in the prefrontal cortex, hippocampus, and basal ganglia. It plays roles in mood, anxiety, and memory consolidation. 5-HT2B signaling also affects neurogenesis and neural stem cell proliferation. Dysregulation is implicated in neuroinflammation and neurodegenerative processes.
Expression Pattern
5-HT2B receptor expression in the brain includes:
Cerebral [Cortex](/brain-regions/cortex): Highest expression in layers II-III and V of the prefrontal cortex
[Hippocampus](/brain-regions/hippocampus): Prominent expression in CA1-CA3 regions and dentate gyrus
Basal Ganglia: Moderate expression in striatum and substantia nigra
Amygdala: Specific expression in basolateral and central nuclei
Thalamus: Limited expression in midline nuclei
Brainstem: Expression in dorsal raphe nucleus and serotonin cell bodies
Role in Neurodegeneration
HTR2B is implicated in neurodegenerative diseases through various mechanisms:
Alzheimer's Disease
Dysregulation of HTR2B signaling affects amyloid processing through [APP](/entities/app-protein) cleavage pathway modulation
Alters [tau](/proteins/tau) phosphorylation via GSK3β and [CDK5](/proteins/cdk5-protein) interactions
Impacts synaptic plasticity and memory consolidation
Modulates neuroinflammation through microglial activation
Parkinson's Disease
Altered expression contributes to dopaminergic neuron vulnerability
Affects neuroinflammation in the substantia nigra
May influence Lewy body formation through protein aggregation pathways
Therapeutic Implications
Drug Development Targets
Agonists: Potential for mood and cognitive enhancement
Antagonists: May provide neuroprotection in specific contexts
biased Ligands: Target specific signaling pathways to maximize therapeutic benefit
Clinical Considerations
Peripheral 5-HT2B activation can cause cardiac valvulopathy
CNS-penetrant selective ligands needed for neurological applications
Combination therapies with other neurotransmitter systems may be beneficial
Research Directions
Key areas for future research include:
Development of brain-penetrant selective 5-HT2B ligands
Understanding biased signaling through specific downstream pathways
Biomarker development for 5-HT2B-related neurodegeneration
The study of Serotonin Receptor 2B Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
Serotonin Receptor 2B Gene - Gene page for HTR2B
Serotonin Receptors - Category of serotonin receptors
[Berger M, et al, (2012) (2012)](https://pubmed.ncbi.nlm.nih.gov/22248378/)
[Unknown, Nichols DE, Nichols CD (2008). Serotonin receptors (2008)](https://pubmed.ncbi.nlm.nih.gov/18620349/)
[Unknown, Leysen JE (2004). 5-HT2 receptors (2004)](https://pubmed.ncbi.nlm.nih.gov/15578960/)
[Unknown, Halberstadt AL, Geyer MA (2011). Multiple receptors contribute to the behavioral effects of 5-HT agonists (2011)](https://pubmed.ncbi.nlm.nih.gov/20881948/)
[Kage T, et al, (2022) (2022)](https://pubmed.ncbi.nlm.nih.gov/35644219/)